EUVIMED · CrossrefZeitschrift
European Respiratory Journal
ISSN 0903-1936 · European Respiratory Society (ERS)
Neueste Artikel
The natural history of interstitial lung disease in common variable immunodeficiency
Ambient Air Pollution, Climate, Land Use, and Small-Area Incidence of Interstitial Lung Disease: A Bi-National Semi-Ecological Study
Major bleeding in patients with acute pulmonary embolism: results from the COPE study
Anti-inflammatory effects of inhaled corticosteroids-containing treatment for symptom relief: a randomized crossover trial in asthma
Ultrasensitive immunoassays reveal no diagnostic Mtb antigens in exhaled breath condensate
2026 Global Initiative for Asthma (GINA) strategy report: executive summary and key changes
The regulatory landscape in tuberculosis integrated research platforms
Vasculitis and risk of bronchiectasis in alpha-1 antitrypsin deficiency subjects from the EARCO registry
Eurotransplant experience with model for end-stage liver disease standard exceptions for hepatopulmonary syndrome and portopulmonary hypertension
Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study
Paediatric drug-resistant tuberculosis in the End TB era: interpreting the residual burden
BMP3: a new kid on the block in pulmonary arterial hypertension
Unravelling the mysteries of long COVID: what the microbiome can tell us
When can a negative endosonographic examination be trusted?
Towards global equity in access to medical devices
LAM cells: “now you see it, now you don't”
Whose outcomes count? Global representation in community-acquired pneumonia outcome standardisation
Targeting neutrophilic inflammation in COPD: rethinking, refining and reprogramming
Reply to: When can a negative endosonographic examination be trusted?
Reply: Core outcome sets for pneumonia: the beginning, not the end
Decoding the lymphangioleiomyomatosis niche microenvironment via integrative analysis of single cell multiomics and spatial transcriptomics
Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with COPD
A frequent ancestral intronic founder variant in DNAI1 causes primary ciliary dyskinesia
Fibrosis extent on HRCT: the principal structural imaging biomarker for antifibrotic trials
Don't discard the supernatant: pleural fluid cfDNA for molecular profiling in lung cancer
Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways
ERS/ESRS clinical practice guideline for continuous positive airway pressure for the treatment of adult obstructive sleep apnoea
Estimating mean pulmonary arterial pressure in the machine learning era
Reply to: Estimating mean pulmonary arterial pressure in the machine learning era
Jahrgänge
2026 · 2762025 · 3702024 · 3692023 · 3792022 · 4972021 · 5432020 · 6952019 · 5562018 · 5452017 · 6882016 · 5942015 · 5532014 · 6172013 · 5252012 · 5382011 · 5622010 · 5122009 · 4842008 · 5262007 · 4282006 · 4522005 · 4032004 · 4122003 · 4762002 · 4622001 · 4132000 · 4551999 · 5981998 · 5071997 · 5081996 · 5021995 · 3701994 · 3721993 · 2661992 · 2201991 · 2141990 · 2501989 · 1751988 · 182
EUVIMED